Page last updated: 2024-11-07

deoxy-5-methylcytidylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Deoxy-5-methylcytidylic acid, also known as 5-methyldeoxycytidine monophosphate or dCMP, is a nucleoside monophosphate that is a component of DNA. It is formed by the methylation of deoxycytidylic acid (dCMP) at the 5-position of the cytosine base. dCMP is synthesized in the body from deoxyribose-1-phosphate, ATP, and CTP through a series of enzymatic reactions. 5-methyldeoxycytidine is incorporated into DNA during replication and is a common modification found in mammalian genomes. dCMP is involved in the regulation of gene expression through its role in methylation. The methylation of cytosine to 5-methylcytosine is a key epigenetic modification that can alter gene expression without changing the underlying DNA sequence. 5-methylcytosine is a key component of CpG islands, which are regions of DNA that are particularly enriched in CpG dinucleotides. CpG islands are often located near the promoters of genes and are involved in the regulation of gene expression. The study of dCMP is important for understanding the mechanisms of DNA replication, repair, and gene expression. It is also important for understanding the role of epigenetic modifications in disease. Deoxy-5-methylcytidylic acid is often investigated in the context of cancer research. It is being studied for its potential role in cancer development and progression. Research is also underway to develop drugs that target dCMP methylation as a potential cancer therapy.'

2'-deoxy-5-methyl-5'-cytidylic acid : A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate having 5-methylcytidine as the nucleobase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID102276
CHEBI ID16764
SCHEMBL ID502418
MeSH IDM0050339

Synonyms (26)

Synonym
2498-41-1
CHEBI:16764
2'-deoxy-5-methyl-5'-cytidylic acid
2'-deoxy-5-methylcytidine 5'-monophosphate
deoxy-5-methylcytidylic acid
deoxy-5-methylcytidylate
C03495
5-methyl-2'-deoxy-cytidine-5'-monophosphate
5CM ,
2'-deoxy-5-methylcytidine 5'-(dihydrogen phosphate)
[(2r,3s,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate
einecs 219-690-1
5-methyldeoxycytidine 5'-monophosphate
5-methyl-deoxycytidylic acid
5-methyl-2'-deoxycytidine monophosphate
SCHEMBL502418
AC-32429
5-methyl-2'-deoxycytidine 5'-monophosphate
DTXSID90179693
5-methyl-2'-deoxycytidine5'-monophosphate
Q27102063
CS-0450332
((2r,3s,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1(2h)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
{[(2r,3s,5r)-5-(4-amino-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid
F87247
5'-cytidylic acid, 2'-deoxy-5-methyl-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
2'-deoxycytidine phosphate
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]